ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2475

Identifying Key Variables for Inclusion in a Smartphone App to Support Clinical Care and Research in Patients with Rheumatoid Arthritis

William G Dixon1, Caroline Sanders2 and Lynn Austin3, 1Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, Great Britain, 2Institute of Population Health, Centre for Primary Care, The University of Manchester, Manchester, United Kingdom, 3Centre for Primary Care, University of Manchester (UK), Manchester M21 9JD, United Kingdom

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: digital technologies, patient outcomes and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Treatment for patients with rheumatoid arthritis (RA) is shaped by monitoring changes in disease severity over time. At present, clinicians managing RA have few (or no) objective measurements of disease activity between clinic visits, even though a number of patient related outcomes measures (PROMs) exist. Smartphones provide a possible solution to allow regular monitoring of disease severity between clinic visits with integration into electronic medical records. Benefits could include better information for consultations, triaging of outpatient appointments and aiding patient self-management. Such data can also support novel research by providing temporally-rich data. REMORA (REmote MOnitoring of Rheumatoid Arthritis) is a study which is designing, implementing and evaluating a system of remote data collection for people with RA for health and research purposes. The project asks whether electronic collection of patient reported outcomes (ePROS) directly from patients between clinic visits can enhance clinical care and provide a sustainable source of data for research. The aim of this paper is to describe the process of determining the ePROS for inclusion in the app, in preparation for piloting the app in clinical practice, and to present the final dataset.

Methods: This study obtained stakeholders’ views on the potential value of recording a range of ePROS. Interviews were conducted with 10 RA practitioners (clinicians, nurses and physiotherapists), 12 RA researchers and 21 patients. Interviews determined provisional ePROSs for inclusion, recording frequency, and value of a free text diary. Table 1 summarises the approach to gaining consensus on app components.

Results: All stakeholder groups wanted to capture information on changes in disease activity and the impact of the disease (physically and emotionally).  Practitioners and researchers wanted routine data that had been recorded consistently using existing validated tools (such as the DAS 28 and the HAQ), but saw the value of a diary for recording triggers and alleviators of disease activity. Patients favoured recording notable events (such as flares) as they occurred, however, they could see the benefits of recording data routinely to see patterns in disease activity. The final data set therefore comprised a combination of routine data and a diary (table 2).

Conclusion: Consensus on the key components of the Smartphone app was achieved using the process outlined in table 1. The components shown in table 2 have now been incorporated into the ‘beta app’ in readiness for piloting within clinical practice.  

Table 1: Consensus process

o   Qualitative interviews were conducted with researchers and practitioners to determine their preferences regarding the components of the app and the rationale for their choices

o   A table summarising the key components suggested by practitioners and researchers was generated in preparation for discussion and feedback from the PPI (patient and public involvement) group working alongside the research team

o   The content and wording of the tabulated information was refined in response to suggestions made by the patient group in preparation for patient interviews

o   Qualitative interviews were conducted with patients with RA to determine their preferences regarding the components of the app. Following this open discussion, patients were shown the tabulated information, derived from practitioner and researcher interviews, and patient feedback sought on the suitability of components suggested

o   The components which had widespread consensus across the stakeholder groups were incorporated into the app

o   Suggested components that did not have consensus across all groups, or were beyond the scope of the study, were documented with a view to being incorporated into future developments.  Components suggested included the facility for taking photographs, and linking the app to a device, such as a pedometer, for measuring exercise

o   PPI group members reviewed and commented on the final components prior to their incorporation into the beta app

 

Table 2: Final data set – frequency, components and mode of data capture

Daily question set

Pain Difficulty with physical activities Fatigue Sleep difficulties Physical wellbeing Emotional wellbeing Coping 10 point visual analogue scale

 

Morning stiffness

Fixed 7 point scale (radio button)

Weekly question set

Number of tender joints

Number of swollen joints

Numeric value

 

Global assessment of wellbeing

10 point visual analogue scale

 

Employment status

Yes/No response (radio button)

 

Impact on hours worked

Numeric value

 

Experienced a flare

Yes/No response (radio button)

 

Description of flare

Free text box

Monthly question set

Health Assessment Questionnaire (HAQ)  impact of disease on daily activities  including function, mobility and grooming Fixed point scales (radio button)  plus free text entry box

 


Disclosure: W. G. Dixon, None; C. Sanders, None; L. Austin, None.

To cite this abstract in AMA style:

Dixon WG, Sanders C, Austin L. Identifying Key Variables for Inclusion in a Smartphone App to Support Clinical Care and Research in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/identifying-key-variables-for-inclusion-in-a-smartphone-app-to-support-clinical-care-and-research-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-key-variables-for-inclusion-in-a-smartphone-app-to-support-clinical-care-and-research-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology